CSAM Health Group admitted to trading

Back

Oslo, 9 October 2020 – The eHealth company CSAM Health has today been admitted to trading on Merkur Market (ticker code: CSAM-ME).

CSAM Health recently raised NOK 825 million through a private placement, consisting of NOK 325 million in new shares and NOK 500 million from existing shareholders.  The placement attracted strong interest from Nordic and international investors and was significantly oversubscribed, reported CSAM.  "We are proud and happy for the great interest that CSAM has experienced from both Nordic and international quality investors”, says Sverre Flatby, CEO of CSAM.

“Today represents a milestone in CSAM's history - through this IPO we significantly broaden the shareholder base and thereby gain access to capital to continue our strong expansion”, continues Einar Bonnevie, CFO of CSAM. 

CSAM has also closed a NOK 300 million bond issue, that the company aims to list on Nordic ABM.

CSAM admitted to trading on Merkur Market

Photo: Thomas Brun / NTB

About CSAM Health Group  CSAM is the leading provider of niche eHealth solutions in the Nordics. The company’s leading product portfolio includes innovative niche solutions in connected healthcare, medical imaging, women and children's health, emergency and acute care, medication management, and laboratory information management systems, that enable healthcare providers to access relevant clinical information at the point of care. CSAM is headquartered in Oslo, and has operations in Norway, Sweden, Finland, Denmark, and the UK, as well as a wholly owned software engineering subsidiary in the Philippines. www.csamhealth.com/about-csam/

 

Press Release Footer

About Euronext
Euronext is the leading pan-European market infrastructure, connecting local economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, The Netherlands, Norway and Portugal. With close to 1,500 listed issuers worth €3.8 trillion in market capitalisation as of end September 2020, it has an unmatched blue chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates Euronext Growth® and Euronext Access®, simplifying access to listing for SMEs. Euronext provides custody and settlement services through central securities depositories in Denmark, Norway and Portugal.
For the latest news, find us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2020, Euronext N.V. - All rights reserved.